New hires and promotions in the biopharma industry, including: Amarna, Evolus, Nugenerex.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Chf Solutions, Dia Imaging Analysis, Illuminoss Medical, Medtronic.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ai Biomed, Ambra Health, Axonics Modulation Technologies, Biocartis Group, Boston Scientific, Breathonix, Daxor, D-Mark Biosciences, Ekso Bionics Holdings, Epic Sciences, Exact Sciences, Inflammatix, Insightec, Lantheus Holdings, Lifedojo, Medtronic, Nanox, Novocure, Ontrak, Predicine, Rb Medical Supply, S2 Genomics, Sengenics, Simplify Medical .

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nucleix.

Med-tech firms raising money in public or private financings, including: Advanced Chemotherapy Technologies, Baxter International, Relievant Medsystems.

New hires and promotions in the med-tech industry, including: Jack Nathan, PDI.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apstem, Asieris, Avrobio, Genprex, Insignis, Mesoblast, Oncosec, Pepromene, Rafael, Regeneron, Tricida.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AB2 Bio, Abcellera, Acura, Anabios, Arcus, Astrazeneca, Atyr, Bone Therapeutics, Catalent, Cstone, Dr. Reddy’s, Emulate, Engene, Field Trip, Dr. Reddy’s, Immatics, Immutep, Inivata, Intec, Jaguar, Kodiak, Legochem, Maverick, Mebias, Merck, Moderna, Moleculin, Novocure, Orion, Sanofi, Sorrento, Synedgen, Syneos, Synteract, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aerie, Affyimmune, Anheart, Annovis, Avillion, Biolinerx, Chemocentryx, Connect, Frequency, Hookipa, Humanigen, Immunomolecular, Kiniksa, Kintor, Leap, Leo, Lilly, Mallinckrodt, Moderna, Plus, Regeneron.

Biopharmas raising money in public or private financings, including: AB Science, Abivax, Advanced Chemotherapy, Allakos, Ariz Precision Medicine, Bridgebio, Centrexion, Elpis, Forte, Galecto, Lianbio, Lilly, Myokardia Q32, Scholar Rock, Titan, Ultragenyx.